Financials in USD. Standardized financial statements.
A compact view of how Bicycle Therapeutics plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M | $10.39M | $13.80M | $7.14M | $2.06M | $0 |
| Revenue Growth? | +105.8% | +30.8% | +86.5% | +23.6% | +12.6% | -24.7% | +93.4% | +246.4% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $172.97M | $156.50M | $0 | $0 | $33.15M | $25.54M | $20.76M | $11.87M | $269,289 |
| Gross Profit? | $72.59M | -$137.69M | -$129.52M | $14.46M | $11.70M | -$22.76M | -$11.74M | -$13.63M | -$9.81M | -$269,289 |
| Gross Margin? | +100.0% | -390.3% | -480.1% | +100.0% | +100.0% | -219.0% | -85.1% | -190.9% | -476.0% | 0.0% |
| Operating Expenses? | $320.30M | $72.18M | $60.43M | $131.12M | $77.31M | $29.20M | $14.56M | $28.88M | $18.27M | $13.22M |
| Operating Income? | -$247.72M | -$209.87M | -$189.95M | -$116.65M | -$65.62M | -$51.96M | -$26.30M | -$21.75M | -$16.21M | -$13.49M |
| EBITDA? | -$212.18M | -$164.89M | -$183.40M | -$107.21M | -$64.09M | -$50.68M | -$25.34M | -$21.49M | -$15.88M | -$13.26M |
| Income Before Tax | -$218.81M | -$173.80M | -$179.21M | -$114.24M | -$68.48M | -$51.73M | -$30.86M | -$22.24M | -$16.28M | -$13.53M |
| Income Tax Expense | $152,000 | -$4.76M | $1.46M | -$1.52M | -$1.66M | -$724,000 | -$254,000 | -$396,000 | -$23,000 | -$20,944 |
| Net Income? | -$218.96M | -$169.03M | -$180.66M | -$112.72M | -$66.82M | -$51.01M | -$30.61M | -$21.85M | -$16.26M | -$13.51M |
| EPS? | $-3.16 | $-2.91 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | $-1.64 | $-1.22 | $-0.76 |
| Diluted EPS? | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 | $-2.66 | $-2.77 | $-1.64 | $-1.22 | $-0.76 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality